Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD

被引：0
|
作者：
Heidi Fassnacht-Riederle
Matthias Becker
Nicole Graf
Stephan Michels
机构：
[1] City Hospital Triemli,Department of Ophthalmology
[2] University of Heidelberg,Department of Ophthalmology
[3] Graf Biostatistics,undefined
[4] University of Zurich,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2014年 / 252卷
关键词：
Age-related macular degeneration; Aflibercept; Ranibizumab; Bevacizumab; Tolerance; Tachyphylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1705 / 1709
页数：4
相关论文
共 50 条
  • [41] Real world efficacy and durability of faricimab in patients with neovascular AMD (nAMD) who had sub-optimal response to prior anti-VEGF therapy
    Goodchild, Christine
    Bailey, Clare
    Hernaez, Jimena Soto
    Ahmed, Eslam
    Salvatore, Serena
    EYE, 2024, 38 (16) : 3059 - 3064
  • [42] Choroidal Thickness Changes During Anti-VEGF Therapy for AMD
    Gusson, E.
    Casati, S.
    Spinelli, C.
    Panozzo, G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [43] EXUDATIVE AMD REFRACTORY TO ANTI-VEGF THERAPY IN PATIENTS WITH MALIGNANCY
    Tan, Irene
    Mendis, Randev
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 : 132 - 132
  • [44] The Role of Genetics in Response to Anti-VEGF Therapy for Wet AMD
    Kovach, Jaclyn
    Agarwal, Anita
    Schwartz, Stephen
    Brantley, Milam
    Cade, William
    Haines, Jonathan
    Pericak-Vance, Margaret
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [45] Vision Assessment and Monitoring of Anti-VEGF Therapy in Patients With AMD
    Eisenbarth, W.
    Feucht, N.
    Enders, C.
    MacKeben, M.
    Maier, M.
    Lohmann, C. P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [46] Increased mortality after intravitreal injections of anti-VEGF for neovascular AMD among patients with prior stroke or acute myocardial infarction
    Chen, Yu-Yen
    Lai, Yun-Ju
    Yen, Yung-Feng
    Chou, Pesus
    EYE, 2022, 36 (01) : 153 - 159
  • [47] Increased mortality after intravitreal injections of anti-VEGF for neovascular AMD among patients with prior stroke or acute myocardial infarction
    Yu-Yen Chen
    Yun-Ju Lai
    Yung-Feng Yen
    Pesus Chou
    Eye, 2022, 36 : 153 - 159
  • [48] Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
    de Groot, John F.
    Piao, Yuji
    Hai Tran
    Gilbert, Mark
    Wu, Hua-Kang
    Liu, Jun
    Bekele, B. Nebiyou
    Cloughesy, Tim
    Mehta, Minesh
    Robins, H. Ian
    Lassman, Andrew
    DeAngelis, Lisa
    Camphausen, Kevin
    Chen, Alice
    Yung, W. K. A.
    Prados, Michael
    Wen, Patrick Y.
    Heymach, John V.
    CLINICAL CANCER RESEARCH, 2011, 17 (14) : 4872 - 4881
  • [49] Effect of Anti-VEGF Treatment on Macular RNFL Thickness in AMD
    Chen, Judy
    Miller, Randee C.
    Wanek, Justin
    Zelkha, Ruth
    Lim, Jennifer I.
    Shahidi, Mahnaz
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [50] Anti-VEGF therapy of exudative AMD. Prognostic factors for therapy success
    Heimes, B.
    Lommatzsch, A.
    Zeimer, M.
    Gutfleisch, M.
    Spital, G.
    Pauleikhoff, D.
    OPHTHALMOLOGE, 2011, 108 (02): : 124 - 131
12345